NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Jul 2026 · 6 Jul 2026, 03:52 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jagsonpal Pharmaceuticals Limited · JAGSNPHARM
✦ AI SummaryRegulatory
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
JAGSNPHARM_06072026155237_Reg_74_5__Intimation_June_2026.pdf
View document text
July 6, 2026
The Department of Corporate Services- Listing The Department of Corporate Services- Listing
BSE Ltd, National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex,
Mumbai-400 001 Bandra (E) Mumbai – 400 051
Scrip Code: 507789 Symbol: JAGSNPHARM
Subject: Certificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Dear Sir/ Madam,
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing
herewith a copy of the certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share
Transfer Agent of the Company, for the quarter ended June 30, 2026.
We request you to take the above on record.
Thanking you,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance officer
MCS Share Transfer Agent Limited
179-180, Dsidc Shed, 3rd Floor Okhla Industrial Area, Phase –I New Delhi –110020
PhoneNo:011-41406149-51,Fax:-011-41709881 ,Email: admin@rmcsregistrars.com
Website:www.mcsregistrars.com, CINNO.U67120WB2011PLC165872
Ref. MCSSTA/JSP/06/2026 July 3, 2026
JAGSONPAL PHARMACEUTICALS LIMITED
PLOT NO 412-415
3RD FLOOR NIMAI TOWER
PH-IV ,UDYOG VIHAR SEC-18
GURUGRAM,
HARYANA-122015
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended
30th June 2026
Dear Sir/Madam,
ln accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended 30th
June 2026, we hereby certify/ confirm that within 15 days of receipt of the securities received for dematerialization that:
(a) the securities comprised in the said Certificate(s) of Security have been listed on the Stock Exchanges where the
earlier issued securities are listed ;and
(b) the said Certificate(s) after due verification have been mutilated and cancelled and the name of the depository has
been substituted in our records as the registered owner.
This is for your information and record.
Thanking you,
Yours faithfully,
For MCS Share Transfer Agent Limited
Authorised Signatory